• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰的抗丙型肝炎抗体与非甲非乙型输血后肝炎

Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.

作者信息

van der Poel C L, Reesink H W, Lelie P N, Leentvaar-Kuypers A, Choo Q L, Kuo G, Houghton M

机构信息

Red Cross Blood Bank Amsterdam, The Netherlands.

出版信息

Lancet. 1989 Aug 5;2(8658):297-8. doi: 10.1016/s0140-6736(89)90486-8.

DOI:10.1016/s0140-6736(89)90486-8
PMID:2569103
Abstract

In a prospective study carried out in the Netherlands (1984-86) to establish the incidence of post-transfusion hepatitis non-A, non-B (PTH-NANB) in patients undergoing open heart surgery, 393 patients received 5315 blood product transfusions. PTH-NANB developed in 9 patients (index cases); stored serum samples from these patients and from 9 control patients, matched for age, sex, and number of blood product transfusions, as well as serum samples of all implicated blood products, were selected retrospectively. Sera were tested under code with a radioimmunoassay for the detection of antibodies to hepatitis C virus (anti-HCV). PTH-NANB patients received 151 blood product transfusions and control patients 140. 4 of 9 PTH-NANB patients (3/5 chronic, 1/4 acute resolved hepatitis) and 0/9 controls seroconverted. 7 of the transfusions given to PTH-NANB patients but none of those given to control patients were anti-HCV positive. In 7 of 9 serum sets from PTH-NANB index cases plus implicated donors, either a donor or the recipient was anti-HCV positive. Among the donors implicated in transmission of PTH-NANB there was a strong correlation between raised alanine aminotransferase levels and the presence of anti-HCV antibodies.

摘要

在荷兰开展的一项前瞻性研究(1984 - 1986年)中,为确定接受心脏直视手术患者的输血后非甲非乙型肝炎(PTH - NANB)发病率,393例患者接受了5315次血液制品输注。9例患者发生了PTH - NANB(索引病例);回顾性选取了这些患者以及9例对照患者(按年龄、性别和血液制品输注次数匹配)的储存血清样本,以及所有相关血液制品的血清样本。血清采用编码放射免疫分析法检测丙型肝炎病毒抗体(抗 - HCV)。PTH - NANB患者接受了151次血液制品输注,对照患者接受了140次。9例PTH - NANB患者中有4例(3/5为慢性肝炎,1/4为急性肝炎已缓解)血清学转换,而9例对照患者均未发生血清学转换。给予PTH - NANB患者的输注中有7次抗 - HCV呈阳性,而给予对照患者的输注均无抗 - HCV阳性。在9组来自PTH - NANB索引病例及相关供血者的血清中,有7组供血者或受血者抗 - HCV呈阳性。在与PTH - NANB传播相关的供血者中,丙氨酸转氨酶水平升高与抗 - HCV抗体的存在之间存在很强的相关性。

相似文献

1
Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.荷兰的抗丙型肝炎抗体与非甲非乙型输血后肝炎
Lancet. 1989 Aug 5;2(8658):297-8. doi: 10.1016/s0140-6736(89)90486-8.
2
Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy.意大利北部某地区非甲非乙型输血后肝炎中抗丙型肝炎病毒抗体的发生率
Infection. 1991 Sep-Oct;19(5):336-9. doi: 10.1007/BF01645359.
3
Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.同样,在采用限制性输血策略的情况下,使用第二代抗丙型肝炎病毒酶联免疫吸附试验进行筛查,本可降低心脏直视手术后的输血后丙型肝炎发生率。
Scand J Gastroenterol. 1993 Jul;28(7):581-4. doi: 10.3109/00365529309096091.
4
Infectivity of blood seropositive for hepatitis C virus antibodies.
Lancet. 1990 Mar 10;335(8689):558-60. doi: 10.1016/0140-6736(90)90347-8.
5
Prospective controlled study of post-transfusion hepatitis after cardiac surgery in a large referral hospital in India.印度一家大型转诊医院心脏手术后输血后肝炎的前瞻性对照研究。
Liver. 1992 Jun;12(3):116-20. doi: 10.1111/j.1600-0676.1992.tb00568.x.
6
Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.抗丙型肝炎病毒筛查也将降低低风险地区输血后丙型肝炎的发病率。
Scand J Gastroenterol. 1992 Jun;27(6):443-8. doi: 10.3109/00365529209000103.
7
Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.伦敦非甲非乙型输血后肝炎的低发病率经丙型肝炎病毒血清学证实。
Lancet. 1991 Mar 30;337(8744):753-7. doi: 10.1016/0140-6736(91)91370-a.
8
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.前瞻性随访的急性和慢性非甲非乙型肝炎输血受者中丙型肝炎病毒抗体的检测
N Engl J Med. 1989 Nov 30;321(22):1494-500. doi: 10.1056/NEJM198911303212202.
9
Anti-HCV in post-transfusion hepatitis: deductions from a prospective study.输血后肝炎中的抗丙型肝炎病毒:一项前瞻性研究的推论
J Hepatol. 1991 May;12(3):377-81. doi: 10.1016/0168-8278(91)90843-z.
10
Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population.报告的输血后肝炎发病率下降。对献血者进行丙氨酸氨基转移酶和乙肝核心抗原抗体筛查的贡献以及普通人群的变化。
Arch Intern Med. 1991 Dec;151(12):2445-8. doi: 10.1001/archinte.151.12.2445.

引用本文的文献

1
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.新时代的丙型肝炎病毒:流行病学、预防、诊断及治疗反应预测因素的展望
World J Gastroenterol. 2014 Aug 7;20(29):9633-52. doi: 10.3748/wjg.v20.i29.9633.
2
New antiviral agents for hepatitis C.新型丙型肝炎抗病毒药物。
F1000 Biol Rep. 2012;4:5. doi: 10.3410/B4-5. Epub 2012 Mar 1.
3
Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.
从未注射过,但感染了丙型肝炎病毒:一项针对阿姆斯特丹队列研究中自称从未注射过毒品者的研究。
J Viral Hepat. 2009 Aug;16(8):568-77. doi: 10.1111/j.1365-2893.2009.01105.x. Epub 2009 Feb 23.
4
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.在一组吸毒者中,丙型肝炎病毒发病率在二十年间大幅下降。
Eur J Epidemiol. 2007;22(3):183-93. doi: 10.1007/s10654-006-9089-7. Epub 2007 Mar 3.
5
Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.用于检测1型人类免疫缺陷病毒和丙型肝炎病毒RNA的高灵敏度多重检测法。
J Clin Microbiol. 2002 Jul;40(7):2408-19. doi: 10.1128/JCM.40.7.2408-2419.2002.
6
Clinical guidelines on the management of hepatitis C.丙型肝炎管理临床指南。
Gut. 2001 Jul;49 Suppl 1(Suppl 1):I1-21. doi: 10.1136/gut.49.suppl_1.i1.
7
Interaction of alcohol and hepatitis C virus infection on severity of liver disease.酒精与丙型肝炎病毒感染对肝脏疾病严重程度的相互作用。
Dig Dis Sci. 1999 Jun;44(6):1236-42. doi: 10.1023/a:1026605130185.
8
Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.普通人群及风险人群中丙型肝炎病毒的感染模式、流行病学及慢性化率。
Dig Dis Sci. 1996 Dec;41(12 Suppl):27S-40S. doi: 10.1007/BF02087874.
9
Immunodiagnosis of viral hepatitides A to E and non-A to -E.甲型至戊型病毒性肝炎及非甲非戊型病毒性肝炎的免疫诊断
Clin Diagn Lab Immunol. 1996 May;3(3):247-56. doi: 10.1128/cdli.3.3.247-256.1996.
10
Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.利用重组蛋白鉴定丙型肝炎病毒NS3区域中由HLA - A2呈递的基序阴性人细胞毒性T细胞表位。
J Virol. 1996 Jan;70(1):232-40. doi: 10.1128/JVI.70.1.232-240.1996.